Basics Alumis Inc. Common Stock IPO Date: June 28, 2024 Sector: Healthcare Industry: Biotech Market Cap: $458.37M Activated in VL: True Average Daily Range Avg Daily Range: $0.38 | 4.83% Avg Daily Range (30 D): $0.31 | 6.41% Avg Daily Range (90 D): $0.38 | 6.69% Institutional Daily Volume Avg Daily Volume: .31M Avg Daily Volume (30 D): .68M Avg Daily Volume (90 D): .61M Trade Size Avg Trade Size (Sh.): 84 Avg Trade Size (Sh.) (30 D): 94 Avg Trade Size (Sh.) (90 D): 90 Institutional Trades Total Inst.Trades: 25 Avg Inst. Trade: $2.09M Avg Inst. Trade (30 D): $.75M Avg Inst. Trade (90 D): $1.09M Avg Inst. Trade Volume: .22M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.38M Avg Closing Trade (30 D): $.86M Avg Closing Trade (90 D): $1.28M Avg Closing Volume: 358.18K         News May 21, 2025 @ 1:10 PM Alumis Completes Merger with ACELYRIN Source: Globe Newswire May 13, 2025 @ 5:00 PM Alumis Stockholders Approve Merger with ACELYRIN Source: N/A May 13, 2025 @ 5:00 PM ACELYRIN Stockholders Approve Merger with Alumis t... Source: N/A May 1, 2025 @ 5:30 PM ACELYRIN Reiterates Benefits of Value-Maximizing C... Source: Globe Newswire Apr 21, 2025 @ 10:30 AM Alumis and ACELYRIN Announce Amended Merger Agreem... Source: Globe Newswire Financials   TTM Q1 2025 Q4 2024 Basic EPS $-26.88 $-1.82 $-.23 Diluted EPS $-26.88 $-1.82 $-.23 Revenue $ 17.39M $ 17.39M $ M Gross Profit $ $ $ Net Income / Loss $ -343.35M $ -98.96M $ -94.76M Operating Income / Loss $ -354.69M $ -101.53M $ -98.62M Cost of Revenue $ $ $ Net Cash Flow $ 57.42M $ M $ -43.81M PE Ratio